Rathika Krishnasamy

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease

Rathika Krishnasamy, Nicole M. Isbel, Carmel M. Hawley et al. · PLoS ONE · 2015 · 159 citations · Full text

The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality

Rathika Krishnasamy, Nicole M. Isbel, Carmel M. Hawley et al. · Nephrology Dialysis Transplantation · 2014 · 71 citations · Full text

A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients – the HEALTHY-CATH trial

Jennifer Broom, Rathika Krishnasamy, Carmel M. Hawley et al. · BMC Nephrology · 2012 · 61 citations · Full text